Screener
Emergent Biosolutions EBS Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Emergent Biosolutions’s reported figures.
Based on trailing twelve months.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
FAQ
- What is Emergent Biosolutions's free cash flow margin?
- Emergent Biosolutions (EBS) reported free cash flow margin of 11.9% in Q2 2026.
- What is the long-term trend for Emergent Biosolutions's free cash flow margin?
- Over 2 years (2020 to 2025), Emergent Biosolutions's free cash flow margin has grown at a -7.2% compound annual growth rate (CAGR), from 25.4% to 21.9%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Emergent Biosolutions's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude